Pere Barba

MD, PhD
Director of the CAR-T Program, Hospital Vall Hebron, Barcelona
Associate Professor at Autonomous University of Barcelona and Vic University, Barcelona, Spain
Pere Barba is the Clinical lead of Advanced Therapies in the Hematology Department of the Vall Hebron University Hospital. He serves as Associate Professor at the Autonomous University of Barcelona and Vic-UCC University.
He achieved his medical degree and did his Fellowship in Hematology at Hospital Sant Pau in Barcelona. He completed his training at Hôpital Saint Louis in Paris, France and served as Visiting Investigator at the Bone Marrow Transplantation Service at Memorial Sloan Kettering Cancer Center in New York. He obtained his clinical PhD in 2014 by the Autonomous University of Barcelona.
Dr Barba is the Coordinator Elect of the Spanish CAR T-cell working party of the GETH Group, an active member of the acute lymphoblastic leukaemia (ALL)-Spanish PETHEMA Group and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and participates in several Joint Accreditation Committee ISCT-Europe (JACIE) initiatives regarding immune effector cells.
Dr. Barba has focused his main interests on CAR-T cells, immunotherapy, ALL, allogeneic cells, and transplantation, publishing more than 100 articles in peer reviewed journals and book chapters on these areas. He is a member of the Spanish acute lymphoblastic leukaemia Group (PETHEMA) and the ALL-Working Party of the EBMT, participating also in several initiatives of the Joint Accreditation Committee ISCT-Europe